Wisconsin Administrative Code (Last Updated: January 10, 2017) |
Agency DHS. Department of Health Services |
Chapters 110-199. Health |
Chapter 157. Radiation Protection |
SubChapter VI. Medical Use of Radioactive Material |
Section 157.68. Radioactive drugs for medical use.
Latest version.
- (1) Preparation. A licensee authorized to manufacture, prepare or transfer for commercial distribution or noncommercial transfer to medical use licensees in a consortium radioactive drugs shall ensure that any individual preparing the drugs is one of the following:(a) An authorized nuclear pharmacist.(b) An individual under the supervision of an authorized nuclear pharmacist.(c) A pharmacist that meets any of the following criteria:1. The requirements for an authorized nuclear pharmacist as specified in s. DHS 157.61 (9) and (11) .2. Is identified as an authorized nuclear pharmacist on a license issued by the department, an agreement state or the NRC.3. Is identified as an authorized nuclear pharmacist by a licensee who is authorized by the department, an agreement state or the NRC to designate authorized nuclear pharmacists operating under their license.4. Functioned as a nuclear pharmacist preparing only radioactive drugs containing accelerator-produced radioactive material, and practiced at a pharmacy at a government agency or federally recognized Indian Tribe before November 30, 2007 or at all other locations of use before August 8, 2009.(2) Documentation. A licensee shall provide to the department a copy of all the following, as appropriate:(a) Each individual's certification by the board of pharmaceutical specialties.(b) The department, NRC or agreement state license.(c) The permit issued by a licensee of broad scope.(d) A list of authorized nuclear pharmacists designated by a licensee under sub. (1) (c) 3.(e) The state pharmacist licensure, no later than 30 days after the date that the licensee allows, under sub. (1) (c) 1. and 2. , the individual to work as an authorized nuclear pharmacist.(f) Documentation that only accelerator-produced radioactive materials were used in the practice of nuclear pharmacy at a government agency or federally recognized Indian Tribe before November 30, 2007 or at all other locations of use before August 8, 2009.
CR 06-021
: cr.
Register October 2006 No. 610
, eff. 11-1-06;
CR 09-062
: am. (1) (intro.) and (2) (e), cr. (1) (c) 4. and (2) (f)
Register April 2010 No. 652
, eff. 5-1-10.